Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR receives positive response from US FDA for phase 3

Sep 18, 2024 at 3:01 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment